We encountered a case of exercise-induced chest pain after the implantation of sirolimus-eluting stents (SESs) 
Introduction

Sirolimus-eluting stents (SESs) have gained widespread use due to the extraordinarily low rates of restensosis (1). Despite these generally superior clinical outcomes, some adverse effects (2) associated with SES implantations including coronary vasoconstriction
and endothelial dysfunction (5) have been reported. We describe a case of exerciseinduced chest pain without any significant coronary stenosis 6 months after the implantation of SESs.
Case Report
A 59-year-old woman was admitted to our hospital with increasing episodes of chest pain on effort. She (Fig. 2B) . After that procedure, she was free of any symptoms and had no significant ECG changes observed during exercise stress testing (Fig. 1B) (Fig. 2C) . Fig. 1C) 
g e a c h e x e r c i s e s t r e s s t e s ti n g ( B , D, E ) .
In order to evaluate her coronary vasoconstriction, an intracoronary administration of 30 μg of acetylcholine was performed, yielding severe coronary vasoconstrictions (Fig. 2D) at the distal portion of the site of the implantation of the SES, associated with significant ST depression in the surface ECG leads II, III, aVF, and V3-6 (
Discussion
We encountered a case of exercise-induced chest pain without significant coronary stenosis 6 months after the implantation of the SESs. The syndrome of chest pain without significant coronary stenosis, but with coronary vasocon-F i g u r e 2 . T h e l e f t c o r o n a r y a n g i o g r a p h y i n t h e r i g h t ( RAO; l e f t p a n e l s ) a n d l e f t ( L AO; r i g h t p a n e l s ) a n t e r i o r o b l i q u e v i e ws o b t a i n e d b e f o r e a p e r c u t a n e o u s c o r o n a r y i n t e r v e n t
i o n ( P CI ) ( A) , j u s t a f t e r P CI ( B ) , 6 mo n t h s a f t e r P CI ( C) , a n d d u r i n g a n i n t r a c o r o n a r y a d mi n i s t r a t i o n o f a c e t y l c h o l i n e ( D) . T h e b l a c k a n d wh i t e a r r o ws i n d i c a t e t h e s t e n t i mp l a n t a t i o n s i t e s a n d c o r o n a r y v a s o c o n s t r i c t i o n s i t e s , r e s p e c t i v e l y .
strictions which are induced by acetylcholine or ergonovine maleate, is diagnosed as vasospastic angina. On the other hand, the syndrome of chest pain with a normal CAG is referred to as microvessel dysfunction, the so called cardiac syndrome X (7). The former condition appears to remain common in Japan, and sometimes causes myocardial infarction and cardiac sudden death (9). Both conditions must be rare complications associated with SES implantations, because few case reports have covered that before (4).
Although the pathogenesis of the coronary microvessel dysfunction and vasospastic angina cannot be completely elucidated, endothelial and/or vascular smooth muscle cell dysfunction has been suggested (10) (11) (12) . It has been reported that the implantation of the SESs caused both anatomical (13, 14) and functional (5, 15) abnormalities of the coronary arteries. In the angioscopic findings at 6 months after the SES implantations, an incomplete re-endothelialization was observed (14) , indicating the existence of impaired endothelial function. Furthermore, the pathologic examination after the implantation of the SES revealed drug or polymerinduced localized vascular inflammatory reactions and/or impaired vessel healing (13, 16, 17) . Moreover, an in vitro study showed that sirolimus impairs the endothelium-derived nitric oxide production leading to endothelial dysfunction and hinders the cell viability (5, 15 
